The American company Pfizer, the drug manufacturer that produces the “Pfizer-Biontech” vaccine against the Corona virus, expected the virus to continue for years, but returned and confirmed that the closures would end after the current wave, this came, quoting Al-Arabiya channel.
And recently, the American drug manufacturer Pfizer announced that it had submitted a request to the Japanese Ministry of Health to approve the release of Covid-19 pills as a treatment for the virus, and if approved, it would make it the second oral drug for mild cases of Corona virus in Japan.
And the official Japanese news agency, Kyodo, reported that the new drug, called Baxilvid, which is a mixture of two antiviral drugs nirmatrelvir and ritonavir, comes at a time when Japan is fighting the sixth wave of Covid-19 cases amid the variable spread of Omicron, as Japan is studying approval to buy what Enough of this drug for about two million people.
Prime Minister Fumio Kishida said earlier last week that a final agreement is expected to be reached with the Japanese arm of US pharmaceutical giant Pfizer Inc on the purchase of the drug by the end of January, with a goal of approval in February.
.